Skip to Content

Home
About
Help
Contact

Switch language English

Switch language

Deutsch English Español Français Italiano Português do Brasil 中文
Login

OpenEmory

Emory University

Emory Libraries

Search

Search Constraints

Start Over Filtering by: Keyword PLUS CETUXIMAB ✖ Remove constraint Keyword: PLUS CETUXIMAB

1 - 7 of 7

relevance date ▼ date ▲

Number of results to display per page

10 per page 20 per page 50 per page 100 per page

View results as:

Search Results

<span itemprop="name">Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer</span>

<span itemprop="name">Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma</span>

<span itemprop="name">Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck</span>

<span itemprop="name">Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era</span>

<span itemprop="name">Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma</span>

<span itemprop="name">EGFR expression and survival in patients given cetuximab and chernoradiation for stage III non-small cell lung cancer: A secondary analysis of RTOG 0324</span>

<span itemprop="name">A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma</span>

Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer

1 of 7

Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

2 of 7

Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck

3 of 7

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era

4 of 7

Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma

5 of 7

EGFR expression and survival in patients given cetuximab and chernoradiation for stage III non-small cell lung cancer: A secondary analysis of RTOG 0324

6 of 7

A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma

7 of 7

Limit your search

Saba, Nabil5
Shin, Dong3
Chen, Georgia2
Ferlito, Alfio2
Nannapaneni, Sreenivas2
Patel, Bhamini2
Steuer, Conor2
Teng, Yong2
Amin, A R M Ruhul1
Ang, K. Kian1
more Authors »

20142
20222
20181
20211
20231

CANCERS3
Molecular Cancer Therapeutics2
CLINICAL CANCER RESEARCH1
Radiotherapy and Oncology1

Article7

Author Accepted Manuscript (After Peer Review)4
Final Published Version3

Life Sciences & Biomedicine7
Oncology7
PLUS CETUXIMAB[remove]7
Science & Technology7
OPEN-LABEL3
GROWTH-FACTOR-RECEPTOR2
HUMAN-PAPILLOMAVIRUS2
PHASE-II TRIAL2
SINGLE-ARM2
immunotherapy2
more Keywords »

About

Help

Contact

Open Access Policy

Version v3.0.0@f82fd7f updated 09 September 2025

Copyright © 2026 Emory University All Rights Reserved. Privacy Policy Copyright Statement | 201 Dowman Drive, Atlanta, Georgia 30322 | 404.727.6123